NCT03840590 (SinoAIADR) is a NA clinical trial of CSK AI system in Colorectal Neoplasms, sponsored by Changhai Hospital.

Who is sponsoring NCT03840590?

NCT03840590 is sponsored by Changhai Hospital.

What drugs are being tested in NCT03840590?

Interventions in NCT03840590: CSK AI system, Standard Colonoscopy.

What condition does NCT03840590 study?

NCT03840590 studies Colorectal Neoplasms, Colonic Polyp, Adenoma.

Is NCT03840590 still recruiting?

NCT03840590 is currently completed. Last updated 25 September 2020.

Last reviewed 2020-09-25 · How we verify

NCT03840590: SinoAIADR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adenoma Detection Rate Using AI System in China

Completed NA Last updated 25 September 2020

What this trial tests

NA trial testing CSK AI system in Colorectal Neoplasms in 743 participants. Completed in 5 December 2019.

Timeline

10 July 2019

Primary endpoint
5 December 2019

5 December 2019

Quick facts

Lead sponsor	Changhai Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	743
Start date	10 July 2019
Primary completion	5 December 2019
Estimated completion	5 December 2019
Sites	4 locations across China

Drugs / interventions tested

CSK AI system
Standard Colonoscopy

Conditions studied

Colorectal Neoplasms — all drugs for Colorectal Neoplasms →
Colonic Polyp — all drugs for Colonic Polyp →
Adenoma — all drugs for Adenoma →

Sponsor

Changhai Hospital

Who can join

Adults 45 to 80, any sex, with Colorectal Neoplasms or Colonic Polyp. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this study is \- to explore the usefulness of Artificial Intelligence system in colonoscopy on adenoma detection rate (ADR). Other aims include to explore the data below when Artificial Intelligence is used. Mean adenomas detected per procedure, MAP Proximal Adenoma detection rate, pADR Polyp detection rate, PDR Proximal polyp detection rate, pPDR Mean polyps detected per procedure, MPP Withdrawal time, WT Cecal intubation rate, CIR Cecal intubation time, CIT

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies.
Nagendran M, Chen Y, Lovejoy CA, Gordon AC, et al · · 2020 · cited 603× · PMID 32213531 · DOI 10.1136/bmj.m689

Verify or expand the search:

Other recruiting trials for Colorectal Neoplasms

Currently open trials in the same condition.

NCT06983639 — Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance · NA · recruiting
NCT07222800 — Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult · Phase 3 · recruiting
NCT07239479 — DEXDES Trial: Dexmedetomidine-Desflurane Combination in Laparoscopic Colectomy · NA · recruiting
NCT07262840 — Health Behavior Change in High-Risk Colorectal Cancer Individuals · NA · recruiting
NCT07257653 — The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line · Phase 2 · recruiting

Other Changhai Hospital trials

Trials by the same sponsor.

NCT07490002 — Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC · Phase 2 · not yet recruiting
NCT07464392 — FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis · NA · recruiting
NCT07507071 — Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions · not yet recruiting
NCT07481591 — Capsule Endoscopy in GI Bleeding: A Retrospective Study · not yet recruiting
NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03840590 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Changhai Hospital
Last refreshed: 25 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03840590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing